For the third year running, employers are staring down near-double-digit healthcare trend. According to Aon, U.S. employer healthcare costs are expected to rise 9.5% in 2026, pushing average cost above $17,000 per employee. With benefit renewal season underway, HR and benefits leaders are searching for cost-mitigation answers that actually hold up under scrutiny.
This article breaks down what the 2026 projections really say, names the cost drivers worth worrying about, and explains, honestly, which prevention strategies have the evidence to back up their ROI claims and which don't.
How Much Are Employer Healthcare Costs Rising in 2026?
The convergence across different methodologies is what makes the 2026 numbers so notable. An actuarial model and two large employer surveys all landed in the same place:
| Source | 2026 Projection | Notable Detail |
|---|---|---|
| Aon | 9.5% increase | Exceeds $17,000 per employee; third straight near-double-digit year |
| Mercer | 6.5% increase | Highest since 2010; would have been ~9% without plan-design changes |
| Business Group on Health | 9% median trend | 7.6% after design changes; ~62% above 2017 levels on a compounded basis |
| PwC | 8.5% medical trend | Fourth consecutive elevated year (group market) |
According to Mercer, even after employers applied planned cost-cutting measures, the projected 6.5% per-employee increase still represents the highest jump since 2010. The Business Group on Health survey adds a sobering long view: on a compounded basis, 2026 costs run roughly 62% above where they sat in 2017.
What's Driving the 2026 Healthcare Cost Increase?
This is where the cost story connects directly to prevention. The Centers for Disease Control and Prevention reports that 90% of the nation's roughly $5.3 trillion in annual health spending goes toward people with chronic and mental-health conditions. (One thing worth flagging: that figure describes spending for people with these conditions, not spending solely caused by them, a distinction recent fact-checks have called out.)
The GLP-1 Factor
GLP-1 medications have become one of the biggest line items on the 2026 cost ledger. Prescriptions for these drugs rose an estimated 700% between 2019 and 2023, and they can run up to roughly $10,000 per member per year.
Here's the part that matters for benefits strategy: GLP-1 results often don't last without behavioral support. Studies suggest a large share of users stop taking them within a year, and many regain the weight afterward. That sustainability gap is exactly why an estimated 38% of employers covering GLP-1s already require employees to take part in a lifestyle behavior-change program as a condition of coverage.
Does Prevention Actually Lower Healthcare Costs? An Honest Look at the ROI
This is the most important point in any conversation about wellness ROI, and the one that gets glossed over most often. The evidence splits sharply along a single line: study design.
Why the Old Wellness ROI Stats Don't Hold Up
For years, the wellness industry leaned on a 2010 meta-analysis that reported a $3.27 medical-cost return for every $1 invested. The catch: that finding was built largely on observational studies, which compare program volunteers (who tend to be healthier and more motivated to begin with) against non-participants. That bakes selection bias right into the result.
When the same lead researchers ran a rigorous randomized controlled trial (published in JAMA in 2019), the broad program showed no significant effect on health outcomes, spending, or absenteeism over 18 months. The separately conducted Illinois Workplace Wellness Study reached the same null conclusion, and its results statistically ruled out the ROI figures from the earlier meta-analysis.
Where Prevention Demonstrably Works
The strongest positive evidence comes from structured, coaching-based, condition-specific programs, and it's genuinely compelling. Take the Diabetes Prevention Program (DPP) model:
- A 2022 single-blind randomized controlled trial (PREDICTS, n=599) of a digital DPP with lifestyle coaching, peer support, and tracking found significant reductions in HbA1c, weight, and cardiovascular risk versus the control group.
- A workforce claims study found that digital-DPP participants spent roughly $1,169 less per person in the year after enrolling than a matched comparison group.
- The CDC's National DPP Coverage Toolkit cites an analysis finding enrollment had an 88% probability of saving money, with roughly $160,000 saved per diabetes case prevented.
The pattern is clear. Broad "get healthy" programming underdelivers. Targeted, sustained, coaching-driven help for higher-risk employees is the version of prevention that actually has receipts.
What This Means for Your 2026 Benefits Strategy
For benefits leaders building 2026 plans, three principles follow from the evidence:
Where Avidon Health Fits
The evidence above points to a specific kind of program: structured, coaching-driven, and built for sustained engagement rather than one-time touchpoints. That model is the foundation of Avidon Health's platform, which is built on cognitive behavioral training methodology and focuses on the chronic conditions and high-cost groups driving the 2026 trend rather than on generic wellness content.
In practice, that looks like condition-focused coaching and habit-building programs designed to help clinical gains hold over time, whether an employee is managing diabetes, lowering cardiovascular risk, or trying to maintain results from a GLP-1 prescription.
The proof behind the model lives in our efficacy and outcomes report: thirteen studies across 60,000+ participants, including controlled-design and multi-year biometric outcomes.
